Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

DIAGNOS Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for modifying and developing of applications, such as Computer Assisted Retina Analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. Its geographical areas include Canada, the United States, Saudi Arabia, Mexico, Costa Rica and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Post by segltechon Jul 21, 2015 1:59pm
58 Views
Post# 23945425

Warrants expire today - out of the money

Warrants expire today - out of the moneyCompany could have used the cash. However, all those additional shares would not have been good in the long run. Still no annual report (July 2,2014) although I don't believe that would have been helpful. My theory is that the June 30th qtrly report, normally released in mid August (August 18, 2014) will show marked improvements and the share price will increase. This will give them the option of creating a PP at a higher price, if the cash flow and existing funds are not enough to accelerate growth. Have been a shareholder with this firm for a long time and have watched them struggle with their different attempts to become profitable. I believe they have finally got a winner in the health sector and the timing could not be better.
Bullboard Posts